True Wealth Design’s Zura Bio ZURA Stock Holding History

True Wealth Design’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-78	Closed	-$338	–	2854
2025 Q3	$338	Sell	78 -304	-80%	-$547	﹤0.01%	2138
2025 Q2	$402	Buy	382 +287	+302%	+$343	﹤0.01%	1827
2025 Q1	$123	Buy	+95	New	+$150	﹤0.01%	2130

Other funds holding ZURA

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

True Wealth Design's ZURA Position: Q4 2025 in Review

True Wealth Design sold out of Zura Bio (ZURA) in Q4 2025, closing a stake of 78 shares — an estimated $338 sold.

True Wealth Design first reported a position in ZURA in Q1 2025 and held it in 3 quarters. The position peaked at $402 in Q2 2025. 75 funds tracked by Wall St. Rank hold ZURA as of Q4 2025.

True Wealth Design reported no remaining Zura Bio position as of Q4 2025 after selling out during the quarter.
True Wealth Design sold 78 Zura Bio shares in Q4 2025, an estimated $338.
True Wealth Design first reported a position in Zura Bio in Q1 2025 and held it in 3 quarters.
True Wealth Design's Zura Bio position peaked at $402 in Q2 2025.
75 funds tracked by Wall St. Rank held Zura Bio as of Q4 2025.

Based on True Wealth Design's 13F filing for Q4 2025, filed 8 Jan 2026.